Skip to main content
Top
Published in: Virology Journal 1/2008

Open Access 01-12-2008 | Research

HDAC inhibitors stimulate viral transcription by multiple mechanisms

Authors: Lata Balakrishnan, Barry Milavetz

Published in: Virology Journal | Issue 1/2008

Login to get access

Abstract

Background

The effects of histone deacetylase inhibitor (HDACi) treatment on SV40 transcription and replication were determined by monitoring the levels of early and late expression, the extent of replication, and the percentage of SV40 minichromosomes capable of transcription and replication following treatment with sodium butyrate (NaBu) and trichostatin A (TSA).

Results

The HDACi treatment was found to maximally stimulate early transcription at early times and late transcription at late times through increased numbers of minichromosomes which carry RNA polymerase II (RNAPII) transcription complexes and increased occupancy of the transcribing minichromosomes by RNAPII. HDACi treatment also partially relieved the normal down-regulation of early transcription by T-antigen seen later in infection. The increased recruitment of transcribing minichromosomes at late times was correlated to a corresponding reduction in SV40 replication and the percentage of minichromosomes capable of replication.

Conclusion

These results suggest that histone deacetylation plays a critical role in the regulation of many aspects of an SV40 lytic infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Saunders N DA Popa C, Jones S, Dahler A.: Histone deacetylase inhibitors as potential anti-skin cancer agents. Cancer Res 1999,59(2):399-404.PubMed Saunders N DA Popa C, Jones S, Dahler A.: Histone deacetylase inhibitors as potential anti-skin cancer agents. Cancer Res 1999,59(2):399-404.PubMed
2.
go back to reference Cress WD, Seto E: Histone deacetylases, transcriptional control, and cancer. J Cell Physiol 2000,184(1):1-16. 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7CrossRefPubMed Cress WD, Seto E: Histone deacetylases, transcriptional control, and cancer. J Cell Physiol 2000,184(1):1-16. 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7CrossRefPubMed
3.
go back to reference Wade PA: Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Hum Mol Genet 2001,10(7):693-698. 10.1093/hmg/10.7.693CrossRefPubMed Wade PA: Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Hum Mol Genet 2001,10(7):693-698. 10.1093/hmg/10.7.693CrossRefPubMed
4.
go back to reference Workman JL, Kingston RE: Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu Rev Biochem 1998, 67: 545-579. 10.1146/annurev.biochem.67.1.545CrossRefPubMed Workman JL, Kingston RE: Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu Rev Biochem 1998, 67: 545-579. 10.1146/annurev.biochem.67.1.545CrossRefPubMed
6.
go back to reference Whiteley LO, Higgins JM, Purdon MP, Ridder GM, Bertram TA: Evaluation in rats of the dose-response relationship among colonic mucosal growth, colonic fermentation, and dietary fiber. Dig Dis Sci 1996,41(7):1458-1467. 10.1007/BF02088573CrossRefPubMed Whiteley LO, Higgins JM, Purdon MP, Ridder GM, Bertram TA: Evaluation in rats of the dose-response relationship among colonic mucosal growth, colonic fermentation, and dietary fiber. Dig Dis Sci 1996,41(7):1458-1467. 10.1007/BF02088573CrossRefPubMed
7.
go back to reference Gray SG QCN Furge K, Guo X, Teh BT.: Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines. Int J Oncol 2004, 24: 773-795.PubMed Gray SG QCN Furge K, Guo X, Teh BT.: Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines. Int J Oncol 2004, 24: 773-795.PubMed
8.
go back to reference Mitsiades CS MNS McMullan CJ, Poulaki V, Shringarpure R, Hideshima T, Akiyama M, Chauhan D, Munshi N, Gu X, Bailey C, Joseph M, Libermann TA, Richon VM, Marks PA, Anderson KC.: Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications. PNAS 2004, 101: 540-545. 10.1073/pnas.2536759100PubMedCentralCrossRefPubMed Mitsiades CS MNS McMullan CJ, Poulaki V, Shringarpure R, Hideshima T, Akiyama M, Chauhan D, Munshi N, Gu X, Bailey C, Joseph M, Libermann TA, Richon VM, Marks PA, Anderson KC.: Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications. PNAS 2004, 101: 540-545. 10.1073/pnas.2536759100PubMedCentralCrossRefPubMed
9.
go back to reference Peart MJ SGK van Laar RK, Bowtell DD, Richon VM, Marks PA, Holloway AJ, Johnstone RW.: Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. PNAS 2005, 102: 3697-3702. 10.1073/pnas.0500369102PubMedCentralCrossRefPubMed Peart MJ SGK van Laar RK, Bowtell DD, Richon VM, Marks PA, Holloway AJ, Johnstone RW.: Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. PNAS 2005, 102: 3697-3702. 10.1073/pnas.0500369102PubMedCentralCrossRefPubMed
10.
go back to reference Dokmanovic M MPA: Prospects: histone deacetylase inhibitors. J Cell Biochem 2005, 96: 293-304. 10.1002/jcb.20532CrossRefPubMed Dokmanovic M MPA: Prospects: histone deacetylase inhibitors. J Cell Biochem 2005, 96: 293-304. 10.1002/jcb.20532CrossRefPubMed
11.
go back to reference Rasheed WK JRW Prince HM.: Histone deacetylase inhibitors in cancer therapy. Expert Opin Investig Drugs 2007,16(5):659-678. 10.1517/13543784.16.5.659CrossRefPubMed Rasheed WK JRW Prince HM.: Histone deacetylase inhibitors in cancer therapy. Expert Opin Investig Drugs 2007,16(5):659-678. 10.1517/13543784.16.5.659CrossRefPubMed
12.
go back to reference Balakrishnan L, Milavetz B: Histone hyperacetylation in the coding region of chromatin undergoing transcription in SV40 minichromosomes is a dynamic process regulated directly by the presence of RNA polymerase II. J Mol Biol 2007,365(1):18-30. 10.1016/j.jmb.2006.09.044PubMedCentralCrossRefPubMed Balakrishnan L, Milavetz B: Histone hyperacetylation in the coding region of chromatin undergoing transcription in SV40 minichromosomes is a dynamic process regulated directly by the presence of RNA polymerase II. J Mol Biol 2007,365(1):18-30. 10.1016/j.jmb.2006.09.044PubMedCentralCrossRefPubMed
13.
go back to reference Van Lint C ES Verdin E.: The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 1996.,5(245-53): Van Lint C ES Verdin E.: The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 1996.,5(245-53):
14.
go back to reference Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R, Pavletich NP: Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 1999,401(6749):188-193. 10.1038/43710CrossRefPubMed Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R, Pavletich NP: Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 1999,401(6749):188-193. 10.1038/43710CrossRefPubMed
15.
go back to reference Balakrishnan L, Milavetz B: Reorganization of RNA polymerase II on the SV40 genome occurs coordinately with the early to late transcriptional switch. Virology 2006,345(1):31-43. 10.1016/j.virol.2005.09.039CrossRefPubMed Balakrishnan L, Milavetz B: Reorganization of RNA polymerase II on the SV40 genome occurs coordinately with the early to late transcriptional switch. Virology 2006,345(1):31-43. 10.1016/j.virol.2005.09.039CrossRefPubMed
16.
go back to reference Eadara JK, Lutter LC: RNA polymerase locations in the simian virus 40 transcription complex. J Biol Chem 1993,268(29):22020-22027.PubMed Eadara JK, Lutter LC: RNA polymerase locations in the simian virus 40 transcription complex. J Biol Chem 1993,268(29):22020-22027.PubMed
17.
go back to reference Kelly TJ, Brown GW: Regulation of chromosome replication. Annu Rev Biochem 2000, 69: 829-880. 10.1146/annurev.biochem.69.1.829CrossRefPubMed Kelly TJ, Brown GW: Regulation of chromosome replication. Annu Rev Biochem 2000, 69: 829-880. 10.1146/annurev.biochem.69.1.829CrossRefPubMed
19.
go back to reference Valls E, Blanco-Garcia N, Aquizu N, Piedra D, Estaras C, de la Cruz X, Martinez-Balbas MA: Involvement of chromatin and histone deacetylation in SV40 T antigen transcription regulation. Nucleic Acids Res 2007,35(6):1958-1968. 10.1093/nar/gkl1113PubMedCentralCrossRefPubMed Valls E, Blanco-Garcia N, Aquizu N, Piedra D, Estaras C, de la Cruz X, Martinez-Balbas MA: Involvement of chromatin and histone deacetylation in SV40 T antigen transcription regulation. Nucleic Acids Res 2007,35(6):1958-1968. 10.1093/nar/gkl1113PubMedCentralCrossRefPubMed
20.
go back to reference Mitsudomi T, Kimura G: Effects of sodium n-butyrate on entry into S phase in resting rat 3Y1 cells infected with simian virus 40. J Virol 1985,56(3):951-957.PubMedCentralPubMed Mitsudomi T, Kimura G: Effects of sodium n-butyrate on entry into S phase in resting rat 3Y1 cells infected with simian virus 40. J Virol 1985,56(3):951-957.PubMedCentralPubMed
21.
go back to reference Goldberg YP, Leaner VD, Parker MI: Elevation of large-T antigen production by sodium butyrate treatment of SV40-transformed WI-38 fibroblasts. J Cell Biochem 1992,49(1):74-81. 10.1002/jcb.240490113CrossRefPubMed Goldberg YP, Leaner VD, Parker MI: Elevation of large-T antigen production by sodium butyrate treatment of SV40-transformed WI-38 fibroblasts. J Cell Biochem 1992,49(1):74-81. 10.1002/jcb.240490113CrossRefPubMed
22.
go back to reference Davie JR: Inhibition of histone deacetylase activity by butyrate. J Nutr 2003,133(7 Suppl):2485S-2493S.PubMed Davie JR: Inhibition of histone deacetylase activity by butyrate. J Nutr 2003,133(7 Suppl):2485S-2493S.PubMed
23.
go back to reference Monneret C: Histone deacetylase inhibitors for epigenetic therapy of cancer. Anticancer Drugs 2007,18(4):363-370. 10.1097/CAD.0b013e328012a5dbCrossRefPubMed Monneret C: Histone deacetylase inhibitors for epigenetic therapy of cancer. Anticancer Drugs 2007,18(4):363-370. 10.1097/CAD.0b013e328012a5dbCrossRefPubMed
24.
go back to reference Roman A: Alteration in the simian virus 40 maturation pathway after butyrate-induced hyperacetylation of histones. J Virol 1982,44(3):958-962.PubMedCentralPubMed Roman A: Alteration in the simian virus 40 maturation pathway after butyrate-induced hyperacetylation of histones. J Virol 1982,44(3):958-962.PubMedCentralPubMed
25.
go back to reference Dynan WS, Tjian R: Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell 1983,32(3):669-680. 10.1016/0092-8674(83)90053-3CrossRefPubMed Dynan WS, Tjian R: Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell 1983,32(3):669-680. 10.1016/0092-8674(83)90053-3CrossRefPubMed
26.
go back to reference Hermansen R, Sierra MA, Johnson J, Friez M, Milavetz B: Identification of Simian virus 40 promoter DNA sequences capable of conferring restriction endonuclease hypersensitivity. J Virol 1996,70(6):3416-3422.PubMedCentralPubMed Hermansen R, Sierra MA, Johnson J, Friez M, Milavetz B: Identification of Simian virus 40 promoter DNA sequences capable of conferring restriction endonuclease hypersensitivity. J Virol 1996,70(6):3416-3422.PubMedCentralPubMed
27.
go back to reference Ghosh AK, Mori Y, Dowling E, Varga J: Trichostatin A blocks TGF-beta-induced collagen gene expression in skin fibroblasts: involvement of Sp1. Biochem Biophys Res Commun 2007,354(2):420-426. 10.1016/j.bbrc.2006.12.204CrossRefPubMed Ghosh AK, Mori Y, Dowling E, Varga J: Trichostatin A blocks TGF-beta-induced collagen gene expression in skin fibroblasts: involvement of Sp1. Biochem Biophys Res Commun 2007,354(2):420-426. 10.1016/j.bbrc.2006.12.204CrossRefPubMed
28.
go back to reference Friez M, Hermansen R, Milavetz B: Chromatin structure of the simian virus 40 late promoter: a deletional analysis. J Virol 1999,73(3):1990-1997.PubMedCentralPubMed Friez M, Hermansen R, Milavetz B: Chromatin structure of the simian virus 40 late promoter: a deletional analysis. J Virol 1999,73(3):1990-1997.PubMedCentralPubMed
29.
go back to reference Hirt B: Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 1967,26(2):365-369. 10.1016/0022-2836(67)90307-5CrossRefPubMed Hirt B: Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 1967,26(2):365-369. 10.1016/0022-2836(67)90307-5CrossRefPubMed
30.
go back to reference Balakrishnan L, Milavetz B: Histone Hyperacetylation during SV40 Transcription is Regulated By p300 and RNA Polymerase II Translocation. J Mol Biol 2007,371(4):1022-1037. 10.1016/j.jmb.2007.06.080PubMedCentralCrossRefPubMed Balakrishnan L, Milavetz B: Histone Hyperacetylation during SV40 Transcription is Regulated By p300 and RNA Polymerase II Translocation. J Mol Biol 2007,371(4):1022-1037. 10.1016/j.jmb.2007.06.080PubMedCentralCrossRefPubMed
31.
go back to reference IJpenberg A, Tan NS, Gelman L, Kersten S, Seydoux J, Xu J, Metzger D, Canaple L, Chambon P, Wahli W, Desvergne B: In vivo activation of PPAR target genes by RXR homodimers. Embo J 2004,23(10):2083-2091. 10.1038/sj.emboj.7600209PubMedCentralCrossRefPubMed IJpenberg A, Tan NS, Gelman L, Kersten S, Seydoux J, Xu J, Metzger D, Canaple L, Chambon P, Wahli W, Desvergne B: In vivo activation of PPAR target genes by RXR homodimers. Embo J 2004,23(10):2083-2091. 10.1038/sj.emboj.7600209PubMedCentralCrossRefPubMed
32.
go back to reference Sandalon Z OA: Self-assembly and protein-protein interactions between the SV40 capsid proteins produced in insect cells. Virology 1997,237(2):414-421. 10.1006/viro.1997.8796CrossRefPubMed Sandalon Z OA: Self-assembly and protein-protein interactions between the SV40 capsid proteins produced in insect cells. Virology 1997,237(2):414-421. 10.1006/viro.1997.8796CrossRefPubMed
Metadata
Title
HDAC inhibitors stimulate viral transcription by multiple mechanisms
Authors
Lata Balakrishnan
Barry Milavetz
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2008
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-5-43

Other articles of this Issue 1/2008

Virology Journal 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.